First potential biomarker for a debilitating fainting condition

Nearly 90% of those in the largest-to-date study of patients with postural orthostatic tachycardia syndrome had elevated levels of a specific autoantibody. The finding both adds significantly to the evidence that POTS is an autoimmune disorder, and identifies a key biomarker that might allow diagnosis with a simple blood test.

from Top Health News -- ScienceDaily https://ift.tt/3181Xib